{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:09:29Z","timestamp":1779167369670,"version":"3.51.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Asparaginase is a crucial drug in acute lymphoblastic leukemia (ALL) treatment, but its use is frequently complicated by asparaginase-associated pancreatitis (AAP). Although several risk factors for AAP have been identified, no comprehensive predictive model is currently available to assess individual patient risk. We aimed to develop and validate a nomogram for AAP risk in children with ALL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study of 352 children with ALL diagnosed at Hebei Children\u2019s Hospital from January 2020 to June 2025, all treated according to the Chinese Children\u2019s Leukemia Group Acute Lymphoblastic Leukemia 2018 (CCLG\u2013ALL\u20132018) protocol. Patients were divided into AAP and non-AAP groups based on the 2012 Atlanta diagnostic criteria for pancreatitis. Clinical data and laboratory parameters were systematically collected. Least absolute shrinkage and selection operator (LASSO) regression was used for variable selection, followed by multivariate logistic regression to construct the prediction model. Model performance was assessed using the receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 352 patients (median age 5.0 years; 56.53% boys), 36 patients (10.23%) developed AAP. Six independent risk factors were identified: history of AAP (odds ratio [OR] = 13.20,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), albumin level (OR = 0.87,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.009), aspartate aminotransferase (OR = 1.01,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), total bilirubin (OR = 1.04,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), blood calcium (OR = 0.01,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003), and blood glucose (OR = 1.74,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). The nomogram model demonstrated excellent discrimination with an area under the curve (AUC) of 0.926 (95% CI: 0.874\u20130.978) and good calibration (Brier score = 0.012). Internal validation confirmed robust performance with a corrected AUC of 0.923 (95% CI: 0.911\u20130.931). DCA indicated a positive net benefit across threshold probabilities of 0.02\u20130.72, suggesting that the model has strong potential for clinical application.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A nomogram incorporating six available clinical and laboratory parameters was successfully developed and validated to predict AAP risk in children with ALL. The model demonstrated excellent predictive performance and clinical applicability, providing a valuable tool for early identification of high-risk AAP patients and guiding individualized preventive strategies to optimize treatment outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1767417","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:22:29Z","timestamp":1779164549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Nomogram-based prediction of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a retrospective study"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiangyu","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Hebei Provincial Clinical Research Center for Child Health and Disease","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Hebei Provincial Clinical Research Center for Child Health and Disease","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenhong","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Hebei Provincial Clinical Research Center for Child Health and Disease","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yile","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Hebei Provincial Clinical Research Center for Child Health and Disease","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.metabol.2009.03.024","article-title":"Sex hormones and metabolic syndrome in children and adolescents","volume":"58","author":"Agirbasli","year":"2009","journal-title":"Metabolism"},{"key":"B2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/0972-5229.178182","article-title":"Hypocalcemia in acute pancreatitis revisited","volume":"20","author":"Ahmed","year":"2016","journal-title":"Indian J. Crit. Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e89198","DOI":"10.7759\/cureus.89198","article-title":"Incidence of PEG-asparaginase-induced pancreatitis in children during acute lymphoblastic leukemia treatment: a multicenter study","volume":"17","author":"Alrasheedi","year":"2025","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/(sici)1096-911x(200003)34:3<200::aid-mpo7>3.0.co;2-t","article-title":"Pegaspargase-induced pancreatitis","volume":"34","author":"Alvarez","year":"2000","journal-title":"Med. Pediatr. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12876-024-03314-8","article-title":"Is serum albumin a pivotal biomarker in anticipating acute pancreatitis outcomes?","volume":"24","author":"Amri","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis\u20132012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.3390\/jcm10214815","article-title":"Genetic variation in ABCC4 and CFTR and acute pancreatitis during treatment of pediatric acute lymphoblastic leukemia","volume":"10","author":"Bartram","year":"2021","journal-title":"J. Clin. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1182\/blood.2025029785","article-title":"Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL","volume":"146","author":"Chen","year":"2025","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3760\/cma.j.cn112140-20220719-00895","article-title":"Report of Chinese children\u2019s cancer group acute lymphoblastic leukemia 2015 multicenter study","volume":"60","year":"2022","journal-title":"Chin. J. Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3969\/j.issn.1000-8179.2015.24.289","article-title":"Expert consensus on pegaspargase in the treatment of acute lymphoblastic leukemia and malignant lymphoma in China","volume":"24","year":"2015","journal-title":"Chin. J. Clin. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3760\/cma.j.issn.0253-2727.2018.08.009","article-title":"Management of toxicities associated with pegaspargase in treatment of patients with lymphoid malignancy: experience from 443 cases in a single center","volume":"39","author":"Cong","year":"2018","journal-title":"Chin. J. Hematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ajcn\/26.3.352","article-title":"Calcium metabolism in pancreatic disease","volume":"26","author":"D'Souza","year":"1973","journal-title":"Am. J. Clin. Nutr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1515\/CCLM.2007.259","article-title":"Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome","volume":"45","author":"Dimitrijevic-Sreckovic","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1517\/14656566.8.12.1977","article-title":"PEG-Asparaginase","volume":"8","author":"Fu","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/ars.2016.6755","article-title":"The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus","volume":"26","author":"Gerber","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"B16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40272-021-00463-1","article-title":"Asparaginase-associated pancreatitis in pediatric patients with acute lymphoblastic leukemia: current perspectives","volume":"23","author":"Gibson","year":"2021","journal-title":"Paediatr. Drugs."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.1200\/JCO.2024.42.16_suppl.6530","article-title":"Achievement of therapeutic levels using dose-reduced peg-asparaginase in adult patients with acute lymphoblastic leukemia","volume":"42","author":"Goldberg","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1606261","DOI":"10.3389\/fonc.2025.1606261","article-title":"Risk factors and outcome of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia","volume":"15","author":"Hassan","year":"2025","journal-title":"Front. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5297143","DOI":"10.1155\/2017\/5297143","article-title":"Serum albumin is independently associated with persistent organ failure in acute pancreatitis","volume":"2017","author":"Hong","year":"2017","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10555-019-09834-0","article-title":"Immunotherapy in pediatric acute lymphoblastic leukemia","volume":"38","author":"Inaba","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.6004\/jnccn.2025.0006","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Inaba","year":"2025","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"B22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00432-025-06333-4","article-title":"Retrospective analysis of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia: focus on rechallenge with pegaspargase","volume":"151","author":"Jia","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/jamaoncol.2025.0613","article-title":"Management of adult acute lymphoblastic leukemia: a review","volume":"11","author":"Kantarjian","year":"2025","journal-title":"JAMA Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/MPA.0000000000002036","article-title":"The characteristics and risk factors of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia","volume":"51","author":"Kuo","year":"2022","journal-title":"Pancreas"},{"key":"B25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3760\/cma.j.cn101070-20230602-00440","article-title":"Analysis of risk factors and severity prediction of acute pancreatitis induced by pegaspargase in children","volume":"39","author":"Lai","year":"2024","journal-title":"Chin. J. Appl. Clin. Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00277-024-06133-9","article-title":"Risk factors and a prediction model of severe asparaginase-associated pancreatitis in children","volume":"104","author":"Lin","year":"2025","journal-title":"Ann. Hematol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1200\/jco.2015.64.5812","article-title":"Clinical and genetic risk factors for acute pancreatitis in patients with acute lymphoblastic leukemia","volume":"34","author":"Liu","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"CD014570","DOI":"10.1002\/14651858.CD014570.pub2","article-title":"PEG-Asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis","volume":"2023","author":"Lynggaard","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"B29","article-title":"Standard for diagnosis and treatment of acute lymphoblastic leukemia in children (2018 edition)","year":"2018","journal-title":"Nation Health Off. Med. Lett. no. 868"},{"key":"B30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/MCG.0000000000000827","article-title":"Risk factors for asparaginase-associated pancreatitis: a systematic review","volume":"51","author":"Oparaji","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1513029","DOI":"10.3389\/fnut.2025.1513029","article-title":"Associations of ALT, AST and ALT\/AST ratio with metabolically unhealthy obesity in the elderly","volume":"24","author":"Shao","year":"2025","journal-title":"Front. Nutr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2352-3026(23)00064-9","article-title":"Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past","volume":"10","author":"Short","year":"2023","journal-title":"Lancet Haematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12098-023-04635-4","article-title":"Relapsed acute lymphoblastic leukemia","volume":"91","author":"Sidhu","year":"2024","journal-title":"Indian J. Pediatr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.exphem.2007.09.005","article-title":"Octreotide prevents L-asparaginase-induced pancreatic injury in rats","volume":"36","author":"Suzuki","year":"2008","journal-title":"Exp. Hematol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/CCO.0000000000001086","article-title":"Immunotherapy in first line treatment of adult acute lymphoblastic leukemia","volume":"36","author":"Torrent","year":"2024","journal-title":"Curr. Opin. Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.3748\/wjg.v12.i35.5705","article-title":"Assessment of oxidative stress in chronic pancreatitis patients","volume":"12","author":"Verlaan","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"B37","first-page":"347","article-title":"Association of asparaginase-associated pancreatitis and ULK2 gene polymorphism","volume":"13","author":"Wang","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1007\/s00277-025-06682-7","article-title":"Relapse risk and outcome of discontinuing asparaginase in children with acute lymphoblastic leukemia","volume":"104","author":"Wang","year":"2025","journal-title":"Ann. Hematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2337\/db24-0931","article-title":"Type 1 diabetes autoantibodies in acute, recurrent acute, and chronic pancreatitis","volume":"74","author":"Wasserfall","year":"2025","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3760\/cma.j.cn101070-20210606-00650","article-title":"Analysis of risk factors in acute lymphoblastic leukemia complicated with acute pancreatitis in children","volume":"37","author":"Wu","year":"2022","journal-title":"Chin. J. Appl. Clin. Pediatr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3870\/j.issn.1004-0781.2022.09.022","article-title":"Clinical characteristics of 31 children with acute lymphoblastic leukemia accompanied with acute pancreatitis treated with polyethylene glycol-conjugated asparaginase","volume":"41","author":"Yu","year":"2022","journal-title":"Her. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/IJGM.S393273","article-title":"Correlation between total bilirubin, total bilirubin\/albumin ratio with disease activity in patients with rheumatoid arthritis","volume":"16","author":"Zhang","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3969\/J.issn.1672-6790.2016.06.024","article-title":"Adverse reactions of PEG-Asparaginase combined with chemotherapy in adult acute lymphoblastic leukemia","volume":"19","author":"Zhou","year":"2016","journal-title":"Chin. J. Clin. Healthc."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1767417\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:22:36Z","timestamp":1779164556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1767417\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":43,"alternative-id":["10.3389\/fphar.2026.1767417"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1767417","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"1767417"}}